Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Global Medical REIT (GMRE-PA) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Global Medical REIT (GMRE-PA) over the last 14 years, with Q3 2025 value amounting to $17.6 million.

  • Global Medical REIT's Cash from Operations rose 775.36% to $17.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.5 million, marking a year-over-year increase of 717.24%. This contributed to the annual value of $70.0 million for FY2024, which is 234.66% up from last year.
  • As of Q3 2025, Global Medical REIT's Cash from Operations stood at $17.6 million, which was up 775.36% from $22.1 million recorded in Q2 2025.
  • In the past 5 years, Global Medical REIT's Cash from Operations registered a high of $23.5 million during Q2 2022, and its lowest value of $12.3 million during Q1 2025.
  • Over the past 5 years, Global Medical REIT's median Cash from Operations value was $17.8 million (recorded in 2021), while the average stood at $17.7 million.
  • Per our database at Business Quant, Global Medical REIT's Cash from Operations soared by 43962.4% in 2021 and then crashed by 2386.83% in 2023.
  • Over the past 5 years, Global Medical REIT's Cash from Operations (Quarter) stood at $17.3 million in 2021, then grew by 5.93% to $18.3 million in 2022, then dropped by 1.0% to $18.1 million in 2023, then rose by 13.23% to $20.5 million in 2024, then fell by 14.41% to $17.6 million in 2025.
  • Its Cash from Operations stands at $17.6 million for Q3 2025, versus $22.1 million for Q2 2025 and $12.3 million for Q1 2025.